Certified by Founder Lodge
Convergent Therapeutics, Inc.
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $90,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer.
Convergent has developed a therapeu
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 04 ,2023 | Series A | $90,000,000 |
The Invus Group
RA Capital Management, L.P.
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Scalvy | $13,900,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
